Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adoptive Transfer of Cord Blood T Cells to Prevent and Treat CMV, EBV and Adenovirus Infections After Transplantation

NCT01923766 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.

NCT NCT01923766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01923766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adoptive Transfer of Cord Blood T Cells to Prevent and Treat CMV, EBV and Adenovirus Infections After Transplantation
Lead sponsor
Children's National Research Institute
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2013
Completion date
March 25, 2020
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adenovirus infections, cmv, ebv